Cost-effectiveness in Canada of azacitidine for the...

Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes

Levy, A.R., Zou, D., Risebrough, N., Buckstein, R., Kim, T., Brereton, N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Current Oncology
DOI:
10.3747/co.21.1311
Date:
November, 2013
File:
PDF, 1.98 MB
english, 2013
Conversion to is in progress
Conversion to is failed